RITUXIMAB BENDAMUSTINE CYTARABINE IS A FEASIBLE AND SAFE INDUCTION REGIMEN PRIOR TO ASCT IN FRONTLINE MCL: A SINGLE CENTER RETROSPECTIVE REAL LIFE EVALUATIONI. Gianesello, M. Nabergoj, A. Branca,T. Berno,F. Lessi,M. Riva,E. De March, R. Zambello,L. Trentin,F. Piazza,G. SemenzatoHAEMATOLOGICA(2017)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要